188 related articles for article (PubMed ID: 28093015)
1. Prevalence and incidence of doctor-diagnosed Dupuytren's disease: a population-based study.
Nordenskjöld J; Englund M; Zhou C; Atroshi I
J Hand Surg Eur Vol; 2017 Sep; 42(7):673-677. PubMed ID: 28093015
[TBL] [Abstract][Full Text] [Related]
2. Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England.
Gerber RA; Perry R; Thompson R; Bainbridge C
BMC Musculoskelet Disord; 2011 Apr; 12():73. PubMed ID: 21486483
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.
Baltzer H; Binhammer PA
Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426
[TBL] [Abstract][Full Text] [Related]
4. A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand.
Mehta S; Belcher HJ
J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):368-72. PubMed ID: 24486152
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Dupuytren's contracture and its correlation with degenerative changes of the hands and feet and with criteria of general health.
Bergenudd H; Lindgärde F; Nilsson BE
J Hand Surg Br; 1993 Apr; 18(2):254-7. PubMed ID: 8501389
[TBL] [Abstract][Full Text] [Related]
6. Dupuytren's interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial.
Dias J; Arundel C; Tharmanathan P; Keding A; Welch C; Corbacho B; Armaou M; Leighton P; Bainbridge C; Craigen M; Flett L; Gascoyne S; Hewitt C; James E; James S; Johnson N; Jones J; Knowlson C; Radia P; Torgerson D; Warwick D; Watson M
Trials; 2021 Sep; 22(1):671. PubMed ID: 34593024
[TBL] [Abstract][Full Text] [Related]
7. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
Sefton AK; Smith BJ; Stewart DA
J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
[TBL] [Abstract][Full Text] [Related]
8. Dupuytren's disease.
Worrell M
Orthopedics; 2012 Jan; 35(1):52-60. PubMed ID: 22229922
[TBL] [Abstract][Full Text] [Related]
9. [Comparative Cost Effectiveness of Clostridium Histolyticum Collagenase (Xiapex®) and Partial Fasciectomy for the Treatment of Dupuytren's Contracture in Austria].
Neuwirth M; Binter A; Pipam W; Rab M
Handchir Mikrochir Plast Chir; 2016 Aug; 48(4):233-8. PubMed ID: 27547932
[TBL] [Abstract][Full Text] [Related]
10. Comparison between Collagenase Injection and Partial Fasciectomy in the Treatment of Dupuytren's Contracture.
Tay TK; Tien H; Lim EY
Hand Surg; 2015 Oct; 20(3):386-90. PubMed ID: 26387998
[TBL] [Abstract][Full Text] [Related]
11. A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.
Harrison E; Tan W; Mills N; Karantana A; Sprange K; Duley L; Elliott D; Blazeby J; Hollingworth W; Montgomery AA; Davis T
Trials; 2017 Aug; 18(1):392. PubMed ID: 28841903
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological study for personal risk factors and quality of life related to Dupuytren's disease in a mountain village of Japan.
Tajika T; Kobayashi T; Kaneko T; Tsunoda D; Tsunoda K; Sutou T; Yamamoto A; Takagishi K
J Orthop Sci; 2014 Jan; 19(1):64-70. PubMed ID: 24129389
[TBL] [Abstract][Full Text] [Related]
13. One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial.
Scherman P; Jenmalm P; Dahlin LB
J Hand Surg Eur Vol; 2016 Jul; 41(6):577-82. PubMed ID: 26631343
[TBL] [Abstract][Full Text] [Related]
14. Dupuytren's disease - what's new: a review.
Żyluk A
Pol Przegl Chir; 2022 Oct; 95(6):53-61. PubMed ID: 38058165
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological profile of Dupuytren's disease in Taiwan (Ethnic Chinese): a nationwide population-based study.
Yeh CC; Huang KF; Ho CH; Chen KT; Liu C; Wang JJ; Chu CC
BMC Musculoskelet Disord; 2015 Feb; 16():20. PubMed ID: 25881036
[TBL] [Abstract][Full Text] [Related]
16. A study of the repeatability of the diagnosis of Dupuytren's contracture and its prevalence in the grampian region.
Lennox IA; Murali SR; Porter R
J Hand Surg Br; 1993 Apr; 18(2):258-61. PubMed ID: 8501390
[TBL] [Abstract][Full Text] [Related]
17. Dupuytren's disease: A reality in Black Africa.
Coulibaly NF; Doumbia MM; Dembele B; Dia R; Fall MEK; Sane AD; Dieme CB
Hand Surg Rehabil; 2020 Oct; 39(5):448-453. PubMed ID: 32380137
[TBL] [Abstract][Full Text] [Related]
18. Evidence-Based Medicine: Options for Dupuytren's Contracture: Incise, Excise, and Dissolve.
Denkler KA; Vaughn CJ; Dolan EL; Hansen SL
Plast Reconstr Surg; 2017 Jan; 139(1):240e-255e. PubMed ID: 28027258
[TBL] [Abstract][Full Text] [Related]
19. Hueston revisited: use of acellular dermal matrix following fasciectomy for the treatment of Dupuytren's disease.
Terry MJ; Sue GR; Goldberg C; Narayan D
Ann Plast Surg; 2014 Dec; 73 Suppl 2():S178-80. PubMed ID: 24691328
[TBL] [Abstract][Full Text] [Related]
20. The burden of productivity loss of U.S. commercially insured patients diagnosed with Dupuytren's disease undergoing collagenase versus fasciectomy treatment.
Vukicevic D; Tatovic S; Zah V; Hurley D; Imro M
Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):127-136. PubMed ID: 32408788
[No Abstract] [Full Text] [Related]
[Next] [New Search]
